טוען...
Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives
Inflammatory bowel disease (IBD) is an idiopathic chronic inflammatory disease of the gastrointestinal system. The spectrum is of predominantly two types, namely, ulcerative colitis and Crohn’s disease. The incidence of IBD has been increasing steadily since 1990, and so the number of agents used in...
שמור ב:
| הוצא לאור ב: | J Inflamm Res |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5961645/ https://ncbi.nlm.nih.gov/pubmed/29844695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JIR.S165330 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|